Case report demonstrates B-vitamin supplementation improves akathisia in a patient with schizophrenia, suggesting nutritional support as a viable strategy.
Key Points
Following B12 supplementation and multimodal therapy, akathisia in the patient resolved and treatment adherence was restored.
The case report highlights the successful application of a therapeutic strategy combining B-vitamin supplementation and antipsychotic switching.
Assessment included folic acid, clobazam, and trihexyphenidyl alongside nutritional support focusing on dopaminergic pathways.
This approach underscores the significance of early akathisia recognition and prompts further trials for standardized treatment protocols.